Procter & Gamble (PG)

Cost of Revenue

$43.36B

TTM · Period ending: · USD

PG logo

PG Cost of Revenue

Latest reported$43.36B
PG TTM Cost of Revenue ($0.00 → $43.36B)
High-resolution chart · PNG

PG cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Procter & Gamble Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
43,362,000,000
43,074,000,000
42,046,000,000
41,630,000,000
41,164,000,000
40,881,000,000
41,042,000,000
40,768,000,000
40,848,000,000
41,113,000,000
41,662,000,000
42,415,000,000
42,760,000,000
42,949,000,000
42,871,000,000
42,638,000,000
42,157,000,000
41,146,000,000
39,742,000,000
38,331,000,000
37,108,000,000
36,259,000,000
36,053,000,000
35,669,000,000
35,250,000,000
35,246,000,000
34,957,000,000
35,007,000,000
34,768,000,000
34,859,000,000
34,816,000,000
34,606,000,000
34,391,000,000
33,661,000,000
33,113,000,000
32,702,000,000
32,535,000,000
32,618,000,000
32,697,000,000
32,859,000,000
32,909,000,000
33,784,000,000
34,796,000,000
35,894,000,000
37,476,000,000
38,138,000,000
39,251,000,000
40,167,000,000
41,007,000,000
41,942,000,000
42,246,000,000
42,652,000,000
42,428,000,000
42,071,000,000
41,964,000,000
41,935,000,000
42,391,000,000
42,681,000,000
42,233,000,000
41,669,000,000
40,552,000,000
39,325,000,000
38,761,000,000
38,210,000,000
37,919,000,000
37,626,000,000
37,518,000,000
37,581,000,000
38,741,000,000
40,282,000,000
40,844,000,000
41,073,000,000
40,034,000,000
38,702,000,000
38,080,000,000
37,339,000,000
36,685,000,000
36,103,000,000
35,386,000,000
34,831,000,000
33,125,000,000
31,520,000,000
30,235,000,000
28,374,000,000
27,838,000,000
27,028,000,000
26,367,000,000
25,820,000,000
25,076,000,000
24,365,000,000
23,365,000,000
22,531,000,000
22,141,000,000
21,842,000,000
21,518,000,000
21,367,000,000
20,989,000,000
21,723,000,000
21,828,000,000
21,906,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.